Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: ARCH THERAPEUTICS, INC.
CIK: 1537561
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2012-05-03
Last Filing Date: 2024-08-19
SEC Filings
Start End Frame Filed ACCN Value View
2021-03-31 CY2021Q1I 2021-12-29 0001104659-21-154314 $ 32,000,000 View
2023-10-01 2023-12-31 CY2023Q4 2024-02-20 0001437749-24-004857 $ 950,000 View
2024-01-01 2024-03-31 CY2024Q1 2024-05-09 0001437749-24-015699 $ 1 View
2015-10-01 2016-09-30 CY2015 2016-12-05 0001144204-16-137852 $ 121,462,897 View
2018-01-01 2018-03-31 CY2018Q1 2018-04-26 0001144204-18-022685 $ 150,302,013 View
2018-04-01 2018-06-30 CY2018Q2I 2018-08-02 0001144204-18-041594 $ 150,550,189 View
2019-04-01 2019-06-30 CY2018Q2 2019-08-01 0001144204-19-037201 $ 168,396,553 View
2012-01-01 2012-03-31 CY2011Q1 2012-05-03 0001165527-12-000396 $ 4,000,000 View
2012-04-01 2012-06-30 CY2011Q2 2012-08-14 0001165527-12-000853 $ 5,172,889 View
2011-10-01 2012-09-30 CY2011 2012-12-31 0001165527-12-001353 $ 4,684,082 View
2012-10-01 2012-12-31 CY2011Q4 2013-02-14 0001165527-13-000175 $ 4,583,204 View
2013-01-01 2013-03-31 CY2012Q1 2013-05-20 0001144204-13-030369 $ 6,030,000 View
2013-04-01 2013-06-30 CY2012Q2 2013-08-14 0001144204-13-046058 $ 8,549,322 View
2017-10-01 2017-12-31 CY2016Q4 2018-02-01 0001144204-18-005155 $ 150,144,575 View
2018-07-01 2018-09-30 CY2017Q3 2018-12-18 0001144204-18-065134 $ 159,778,165 View
2018-10-01 2018-12-31 CY2018Q4 2019-02-01 0001144204-19-004261 $ 161,057,300 View
2019-01-01 2019-03-31 CY2017Q4I 2019-05-14 0001144204-19-025993 $ 163,285,738 View
2019-07-01 2019-09-30 CY2018Q3 2019-11-19 0001104659-19-065500 $ 172,575,820 View
2014-10-01 2015-09-30 CY2014 2015-12-11 0001144204-15-070409 $ 81,394,873 View
2015-10-01 2015-12-31 CY2014Q4 2016-02-12 0001144204-16-081344 $ 108,620,575 View
2016-01-01 2016-03-31 CY2015Q1 2016-04-28 0001144204-16-096898 $ 109,524,010 View
2016-04-01 2016-06-30 CY2015Q2 2016-07-28 0001144204-16-115040 $ 120,999,849 View
2016-10-01 2016-12-31 CY2015Q4 2017-02-01 0001144204-17-005299 $ 135,319,847 View
2017-01-01 2017-03-31 CY2016Q1 2017-05-02 0001144204-17-023801 $ 140,513,488 View
2017-04-01 2017-06-30 CY2016Q2 2017-07-27 0001144204-17-038706 $ 147,019,042 View
2016-10-01 2017-09-30 CY2016 2017-11-15 0001144204-17-059213 $ 142,722,788 View
2019-10-01 2019-12-31 CY2018Q4 2020-01-30 0001104659-20-008519 $ 184,102,916 View
2020-04-01 2020-06-30 CY2019Q2 2020-07-23 0001104659-20-085895 $ 188,340,505 View
2020-10-01 2020-12-31 CY2019Q4 2021-02-12 0001104659-21-021968 $ 193,044,766 View
2021-01-01 2021-03-31 CY2021Q1 2021-05-06 0001104659-21-062236 $ 213,337,625 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-13 0001104659-21-104937 $ 236,719,770 View
2012-10-01 2013-09-30 CY2013 2013-12-27 0001144204-13-069281 $ 21,366,752 View
2012-10-01 2013-09-30 CY2012 2014-05-01 0001144204-14-026915 $ 21,366,752 View
2013-10-01 2013-12-31 CY2012Q4 2014-02-14 0001144204-14-008951 $ 60,145,237 View
2014-01-01 2014-03-31 CY2013Q1 2014-05-15 0001144204-14-031168 $ 67,344,404 View
2014-04-01 2014-06-30 CY2013Q2 2014-08-06 0001144204-14-047210 $ 71,949,564 View
2013-10-01 2014-09-30 CY2014 2014-12-12 0001144204-14-073579 $ 67,492,823 View
2014-10-01 2014-12-31 CY2014Q4 2015-02-09 0001144204-15-006886 $ 73,337,085 View
2015-01-01 2015-03-31 CY2015Q1 2015-05-07 0001144204-15-028272 $ 76,076,487 View
2015-04-01 2015-06-30 CY2015Q2 2015-08-07 0001144204-15-047254 $ 76,804,674 View
2019-07-01 2019-09-30 CY2019Q3 2020-12-11 0001104659-20-134664 $ 172,575,820 View
2020-01-01 2020-03-31 CY2020Q1 2020-05-05 0001104659-20-056804 $ 186,897,947 View
2020-10-01 2021-09-30 CY2021 2021-12-17 0001410578-21-000550 $ 220,001,412 View
2021-10-01 2021-12-31 CY2021Q4 2022-02-11 0001851734-22-000084 $ 0 View
2022-01-01 2022-03-31 CY2021Q1 2022-05-13 0001851734-22-000246 $ 236,865,603 View
2022-04-01 2022-06-30 CY2021Q2 2022-08-11 0001851734-22-000438 $ 236,947,517 View
2021-10-01 2022-09-30 CY2021 2022-12-28 0001851734-22-000752 $ 106,257 View
2022-10-01 2022-12-31 CY2021Q4 2023-02-14 0001851734-23-000065 $ 106,257 View
2022-01-01 2022-03-31 CY2022Q1 2023-05-23 0001437749-23-015498 $ 625 View
2023-04-01 2023-06-30 CY2023Q2I 2023-08-11 0001437749-23-023364 $ 690,015 View
2022-10-01 2023-09-30 CY2023 2024-02-15 0001437749-24-004234 $ 995,000 View
2023-10-01 2024-06-30 CY2024Q2 2024-08-19 0001493152-24-033091 $ 36,232 View
2023-03-31 CY2023Q1I 2024-03-01 0001437749-24-006301 $ 4,000,000 View
SEC Facts By Type
Type Name Description View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable and Accrued Liabilities, Noncurrent Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations. View
us-gaap Accounts Payable and Other Accrued Liabilities, Current Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Liabilities (Deprecated 2009-01-31) Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. For classified balance sheets, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer); for unclassified balance sheets, used to reflect the total liabilities (regardless of due date). View
us-gaap Accrued Liabilities and Other Liabilities Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Rent Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. View
us-gaap Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. View
us-gaap Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets Cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land or leased assets). View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities The aggregate amount of adjustments to net income or loss necessary to remove the effects of all items whose cash effects are investing or financing cash flows. The aggregate amount also includes all noncash expenses and income items which reduce or increase net income and are thus added back or deducted when calculating cash provided by or used in operating activities. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Noncurrent Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash Equivalents, at Carrying Value Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Amount of subscription receivable from investors who have been allocated common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Shares Subscribed but Unissued Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. View
us-gaap Common Stock, Value, Subscriptions Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Contractual Obligation Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. View
us-gaap Contractual Obligation, to be Paid, Year Four Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Contractual Obligation, to be Paid, Year One Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Contractual Obligation, to be Paid, Year Two Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Contractual Obligation, to be Paid, Year Three Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Convertible Notes Payable, Noncurrent Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. View
us-gaap Convertible Notes Payable, Current Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. View
us-gaap Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period. View
us-gaap Costs and Expenses Total costs of sales and operating expenses for the period. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Conversion, Converted Instrument, Warrants or Options Issued "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt, Current Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer. View
us-gaap Long-term Debt, Gross Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. View
us-gaap Debt Instrument, Convertible, Conversion Price The price per share of the conversion feature embedded in the debt instrument. View
us-gaap Debt Instrument, Face Amount Face (par) amount of debt instrument at time of issuance. View
us-gaap Debt Instrument, Interest Rate, Stated Percentage Contractual interest rate for funds borrowed, under the debt agreement. View
us-gaap Debt Instrument, Unamortized Discount Amount, after accumulated amortization, of debt discount. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Inventory Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory. View
us-gaap Deferred Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, Domestic Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, State and Local Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Other Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible tax credit carryforwards, classified as other. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Research Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Derivative Liability, Fair Value, Amount Not Offset Against Collateral Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement. View
us-gaap Derivative, Gain (Loss) on Derivative, Net Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. View
us-gaap Derivative Liability Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset. View
us-gaap Derivative Liability, Current Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. View
us-gaap Derivative Liability, Noncurrent Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. View
us-gaap Derivative, Loss on Derivative Amount of decrease in the fair value of derivatives recognized in the income statement. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
us-gaap Due to Related Parties, Current Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Life Insurance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to life insurance expense. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity The amount of the liability for the conversion option reclassified to stockholders' equity when the embedded option no longer required separation from the host instrument. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Amount of cost not yet recognized for nonvested award under share-based payment arrangement. View
us-gaap Equity Method Investment, Ownership Percentage The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. View
us-gaap Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) Agreed upon price for the exchange of the underlying asset. View
us-gaap Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). View
us-gaap Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. View
us-gaap Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) Risk-free interest rate assumption used in valuing an instrument. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Domestic The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Income Taxes Paid The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. View
us-gaap Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Amount of increase (decrease) in accrued expenses, and obligations classified as other. View
us-gaap Increase (Decrease) in Derivative Liabilities The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer). View
us-gaap Increase (Decrease) in Interest Payable, Net The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. View
us-gaap Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. View
us-gaap Increase (Decrease) in Notes Payable, Related Parties The increase (decrease) during the reporting period in the amount owed by the reporting entry in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. View
us-gaap Increase (Decrease) in Notes Payable, Related Parties, Current The increase (decrease) during the reporting period in the current portion (due within one year or one business cycle, whichever is longer) of the amount owed by the reporting entity in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence. View
us-gaap Increase (Decrease) in Other Accounts Payable Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer. View
us-gaap Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other. View
us-gaap Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Increase (Decrease) in Restricted Cash for Operating Activities The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as operating activities. This may include cash restricted for regulatory purposes. View
us-gaap Interest and Debt Expense Interest and debt related expenses associated with nonoperating financing activities of the entity. View
us-gaap Interest Expense, Debt Amount of the cost of borrowed funds accounted for as interest expense for debt. View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. View
us-gaap Interest Payable, Current Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Inventory, Finished Goods, Gross Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer. View
us-gaap Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. View
us-gaap Inventory, Raw Materials, Gross Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer. View
us-gaap Inventory Valuation Reserves Amount of valuation reserve for inventory. View
us-gaap Inventory, Work in Process, Gross Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer. View
us-gaap Inventory Write-down Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Lessee, Operating Lease, Liability, to be Paid, Year One Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Operating Leases, Future Minimum Payments Due Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. View
us-gaap Operating Leases, Future Minimum Payments Due, Next Twelve Months Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Property, Plant and Equipment, Disposals Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum The maximum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Percentage of vesting of award under share-based payment arrangement. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Inventory, Work in Process, Net of Reserves Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing. View
us-gaap Weighted Average Number of Shares Issued, Basic This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic). View
us-gaap Line of Credit, Current The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Lease, Liability Present value of lessee's discounted obligation for lease payments from operating lease. View
us-gaap Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease. View
us-gaap Cost of Goods Sold (Deprecated 2018-01-31) Total costs related to goods produced and sold during the reporting period. View
us-gaap Derivative, Fair Value, Net Fair value of the assets less the liabilities of a derivative or group of derivatives. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Liabilities Assumed The fair value of liabilities assumed in noncash investing or financing activities. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer. View
us-gaap Long-term Debt Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Notes Payable, Noncurrent Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Financing Activities, Continuing Operations Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Investing Activities, Continuing Operations Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Notes Payable Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Notes Payable, Related Parties, Current The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Notes Payable, Related Parties, Current (Deprecated 2009-01-31) The amount for notes payable (written promise to pay), due to related parties. For classified balance sheets, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer); for unclassified balance sheets, used to reflect the total liabilities (regardless of due date). View
us-gaap Financing Receivable, before Allowance for Credit Loss Amount, before allowance for credit loss, of financing receivable. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Leases, Future Minimum Payments, Due in Two Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Other Income Amount of revenue and income classified as other. View
us-gaap Other Noncash Expense Amount of expense or loss included in net income that result in no cash flow, classified as other. View
us-gaap Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. View
us-gaap Other Revenue, Net (Deprecated 2018-01-31) Amount, after sales adjustments, returns, allowances, and discounts, of revenue classified as other. View
us-gaap Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Prepaid Expense (Deprecated 2009-01-31) Carrying amount for a unclassified balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. For a classified balance sheet, represents the noncurrent portion of prepaid expenses (the current portion has a separate concept). View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Debt The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Proceeds from Issuance of Secured Debt The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt. View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation. View
us-gaap Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. View
us-gaap Proceeds from (Repayments of) Notes Payable Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Pro Forma Weighted Average Shares Outstanding, Diluted The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Property, Plant and Equipment, Gross Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation. View
us-gaap Restricted Stock or Unit Expense Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee The highest quantity of shares an employee can purchase under the plan per period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted Net number of non-option equity instruments granted to participants. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Number of additional shares authorized for issuance under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Number of shares issued under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Number of options vested. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. View
us-gaap Stockholders' Equity, Period Increase (Decrease) The increase (decrease) in stockholders' equity during the period. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Stock Issued During Period, Shares, Acquisitions Number of shares of stock issued during the period pursuant to acquisitions. View
us-gaap Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Stock Issued During Period, Shares, Other Number of shares of stock issued attributable to transactions classified as other. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Acquisitions Value of stock issued pursuant to acquisitions during the period. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Asset Impairment Charges Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Inventory, Finished Goods, Net of Reserves Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale. View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Revenue from Contract with Customer, Including Assessed Tax Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted average price of options that were either forfeited or expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Unrealized Gain (Loss) on Derivatives The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. View
us-gaap Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Debt Issuance Costs, Gross Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement. View
us-gaap Paid-in-Kind Interest Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method. View
us-gaap Payments of Debt Issuance Costs The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. View
us-gaap Repayments of Short-term Debt The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. View
us-gaap Gain (Loss) on Sale of Derivatives The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Deferred Tax Assets, Property, Plant and Equipment Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Proceeds from Issuance of Unsecured Debt The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt. View
us-gaap Proceeds from Short-term Debt The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Derivative Liability, Number of Instruments Held The number of derivative instruments of a particular derivative liability or group of derivative liabilities held by the entity. View
us-gaap Number of Reporting Units Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment. View
us-gaap Accretion Expense Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. View
us-gaap Conversion of Stock, Shares Converted "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap 1853497 None View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Preferred Stock Dividends and Other Adjustments The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. View
us-gaap Stock or Unit Option Plan Expense Amount of noncash expense for option under share-based payment arrangement. View
Chart of Accounts => Accounts
Name View
Accounts Payable and Accrued Liabilities, Noncurrent View
Accounts Payable and Other Accrued Liabilities, Current View
Accounts Payable, Current View
Accrued Liabilities (Deprecated 2009-01-31) View
Accrued Liabilities and Other Liabilities View
Accrued Liabilities, Current View
Accrued Rent View
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment View
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets View
Additional Paid in Capital View
Additional Paid in Capital, Common Stock View
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Adjustments to Additional Paid in Capital, Warrant Issued View
Share-based Payment Arrangement, Expense View
Assets View
Assets, Current View
Assets, Noncurrent View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Cash Equivalents, at Carrying Value View
Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Common Stock, Par or Stated Value Per Share View
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Shares Subscribed but Unissued View
Common Stock, Value, Subscriptions View
Common Stock, Value, Issued View
Contractual Obligation View
Contractual Obligation, to be Paid, Year Four View
Contractual Obligation, to be Paid, Year One View
Contractual Obligation, to be Paid, Year Two View
Contractual Obligation, to be Paid, Year Three View
Convertible Notes Payable, Noncurrent View
Convertible Notes Payable, Current View
Cost of Goods Sold (Deprecated 2018-01-31) View
Cost of Revenue View
Costs and Expenses View
Debt Conversion, Converted Instrument, Amount View
Debt Conversion, Converted Instrument, Warrants or Options Issued View
Debt, Current View
Long-term Debt, Gross View
Debt Instrument, Convertible, Conversion Price View
Debt Instrument, Face Amount View
Debt Instrument, Interest Rate, Stated Percentage View
Debt Instrument, Unamortized Discount View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Inventory View
Deferred Tax Assets, Net View
Deferred Tax Assets, Net of Valuation Allowance View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Operating Loss Carryforwards, Domestic View
Deferred Tax Assets, Operating Loss Carryforwards, State and Local View
Deferred Tax Assets, Tax Credit Carryforwards, Other View
Deferred Tax Assets, Tax Credit Carryforwards, Research View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent View
Deferred Tax Assets, Valuation Allowance View
Depreciation View
Derivative Liability, Fair Value, Amount Not Offset Against Collateral View
Derivative, Fair Value, Net View
Derivative, Gain (Loss) on Derivative, Net View
Derivative Liability View
Derivative Liability, Current View
Derivative Liability, Noncurrent View
Derivative, Loss on Derivative View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Due to Related Parties, Current View
Earnings Per Share, Basic View
Earnings Per Share, Basic and Diluted View
Earnings Per Share, Diluted View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Life Insurance, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent View
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity View
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount View
Equity Method Investment, Ownership Percentage View
Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) View
Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) View
Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) View
Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value View
Gain (Loss) on Extinguishment of Debt View
General and Administrative Expense View
Gross Profit View
Income (Loss) from Continuing Operations before Income Taxes, Domestic View
Income Tax Expense (Benefit) View
Income Taxes Paid View
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities View
Increase (Decrease) in Derivative Liabilities View
Increase (Decrease) in Interest Payable, Net View
Increase (Decrease) in Inventories View
Increase (Decrease) in Notes Payable, Related Parties View
Increase (Decrease) in Notes Payable, Related Parties, Current View
Increase (Decrease) in Other Accounts Payable View
Increase (Decrease) in Other Noncurrent Assets View
Increase (Decrease) in Other Operating Assets View
Increase (Decrease) in Prepaid Expense and Other Assets View
Increase (Decrease) in Prepaid Expense View
Increase (Decrease) in Restricted Cash for Operating Activities View
Interest and Debt Expense View
Interest Expense View
Interest Expense, Debt View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Interest Paid, Excluding Capitalized Interest, Operating Activities View
Interest Payable, Current View
Inventory, Finished Goods, Gross View
Inventory, Net View
Inventory, Raw Materials, Gross View
Inventory Valuation Reserves View
Inventory, Work in Process, Gross View
Inventory Write-down View
Issuance of Stock and Warrants for Services or Claims View
Lessee, Operating Lease, Liability, to be Paid, Year One View
Liabilities View
Liabilities and Equity View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures View
Liabilities Assumed View
Liabilities, Current View
Liabilities, Noncurrent View
Long-term Debt View
Notes Payable, Noncurrent View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Financing Activities, Continuing Operations View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Investing Activities, Continuing Operations View
Net Cash Provided by (Used in) Operating Activities View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Notes Payable View
Notes Payable, Current View
Notes Payable, Related Parties, Current View
Notes Payable, Related Parties, Current (Deprecated 2009-01-31) View
Financing Receivable, before Allowance for Credit Loss View
Operating Expenses View
Operating Income (Loss) View
Operating Lease, Liability View
Operating Lease, Right-of-Use Asset View
Operating Leases, Future Minimum Payments Due View
Operating Leases, Future Minimum Payments Due, Next Twelve Months View
Operating Leases, Future Minimum Payments, Due in Two Years View
Operating Loss Carryforwards View
Other Assets, Noncurrent View
Other Income View
Other Noncash Expense View
Other Noncash Income (Expense) View
Other Revenue, Net (Deprecated 2018-01-31) View
Payments to Acquire Property, Plant, and Equipment View
Preferred Stock, Par or Stated Value Per Share View
Prepaid Expense (Deprecated 2009-01-31) View
Prepaid Expense and Other Assets, Current View
Prepaid Expense, Current View
Proceeds from Convertible Debt View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Debt View
Proceeds from Issuance of Private Placement View
Proceeds from Issuance of Secured Debt View
Proceeds from Issuance or Sale of Equity View
Proceeds from Notes Payable View
Proceeds from Related Party Debt View
Proceeds from (Repayments of) Notes Payable View
Proceeds from Stock Options Exercised View
Proceeds from Warrant Exercises View
Pro Forma Weighted Average Shares Outstanding, Diluted View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Property, Plant and Equipment, Disposals View
Property, Plant and Equipment, Gross View
Property, Plant and Equipment, Net View
Repayments of Notes Payable View
Research and Development Expense View
Restricted Stock or Unit Expense View
Retained Earnings (Accumulated Deficit) View
Revenues View
Selling, General and Administrative Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares View
Share Price View
Shares, Issued View
Stockholders' Equity Attributable to Parent View
Stockholders' Equity, Period Increase (Decrease) View
Stock Issued View
Stock Issued During Period, Shares, Acquisitions View
Stock Issued During Period, Shares, Issued for Services View
Stock Issued During Period, Shares, New Issues View
Stock Issued During Period, Shares, Other View
Stock Issued During Period, Shares, Restricted Stock Award, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Acquisitions View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, Stock Options Exercised View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Asset Impairment Charges View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations View
Inventory, Finished Goods, Net of Reserves View
Inventory, Work in Process, Net of Reserves View
Nonoperating Income (Expense) View
Revenue from Contract with Customer, Including Assessed Tax View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price View
Unrealized Gain (Loss) on Derivatives View
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues View
Weighted Average Number of Shares Issued, Basic View
Debt Issuance Costs, Gross View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent View
Paid-in-Kind Interest View
Payments of Debt Issuance Costs View
Repayments of Short-term Debt View
Gain (Loss) on Sale of Derivatives View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period View
Line of Credit, Current View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Deferred Tax Assets, Property, Plant and Equipment View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Preferred Stock, Value, Issued View
Proceeds from Issuance of Unsecured Debt View
Proceeds from Short-term Debt View
Amortization of Debt Discount (Premium) View
Derivative Liability, Number of Instruments Held View
Number of Reporting Units View
Accretion Expense View
Conversion of Stock, Shares Converted View
1837282 View
Net Income (Loss) Available to Common Stockholders, Basic View
Preferred Stock Dividends and Other Adjustments View
Stock or Unit Option Plan Expense View